Scout | Pragmatic Trials across the Cancer Control Continuum (UG3/UH3 Clinical Trial Required)

This opportunity is no longer accepting applications.

grant

Pragmatic Trials across the Cancer Control Continuum (UG3/UH3 Clinical Trial Required)

The National Cancer Institute is offering funding to advance cancer-related interventions aimed at improving health equity and reflecting the diverse population of the U.S. The research should test the impact of these interventions on cancer outcomes using pragmatic trials. The funding follows a two-phase approach: the UG3 phase focuses on refining the intervention and preparing for the trial,…

Source

Agency: National Institutes of Health

Sub-agency: National Cancer Institute

Program: SBIR

Dates

Opportunity Released: November 23, 2022

Open for Submission: November 23, 2022

Submission Deadline: November 17, 2025

Application Window Closes: November 17, 2025

Keywords

cancer research

health equity

evidence-based interventions

pragmatic trial

cancer control continuum

UG3/UH3 mechanism

National Cancer Institute

cancer-related outcomes

cooperative agreement

study design.

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers